Travis Ruch

Travis Ruch, Ph.D., is a Principal at Charles River Associates since February 2017, where expertise in business strategy consulting focuses on providing quantitative data for pharmaceutical product decisions from pre-launch to post-marketing. Prior to this role, Travis served as a Postdoctoral Fellow at the University of California, San Francisco, researching molecular mechanisms of epithelial cell polarity and innate immunity in Cystic Fibrosis, and completed a doctoral program at Johns Hopkins School of Medicine, studying the roles of the coronavirus E protein. Earlier experience includes work as an Analytical Chemist at Pfizer, ensuring the purity of pharmacological compounds, and an academic background comprising a Bachelor of Science in Chemistry from Hope College.